Vedaly main page

Enhance your R&D team with AI team member

Convert fragmented data into actionable intelligence through human-AI collaboration with Vedaly platform!

Build "Data&AI backbone" of your biopharma organization

From strategy to implementation - our expertise will giude you at every step

Our partners and supporters

AI in biopharma only delivers value when data, analysis, and decisions are tightly connected. Vedaly exists to make that connection real!

We partner with translational and R&D teams to architect scalable data foundations, integrate complex biological and clinical data, and operationalize AI so it directly informs scientific and strategic decisions.

From targeted advisory work to full integration of our collaborative AI platform, we adapt to your goals and maturity - ensuring your AI efforts are credible, actionable, and aligned with how science actually gets done. If AI matters to your roadmap, Vedaly can help you deliver it.

What we do

Collaborative AI Research Platform

Our platform enables translational teams, data science teams and AI to collaborate directly around live scientific evidence — data, analyses, figures, and literature — rather than static reports or disconnected tools. It embeds domain-grounded AI into your workflows and results, improving traceability, iteration, and alignment across teams. The result is faster learning, better decisions, and AI that truly supports how biopharma research works.

Strategic AI & Data Consulting

We work with biopharma leaders to define AI strategies that are grounded in scientific reality and aligned with business goals. From data strategy and architecture to operating models and capability building, we help you make the right decisions early — and avoid costly missteps later. Our role is to bring clarity, structure, and momentum to complex AI initiatives.

Bioinformatics, Analytics & AI Delivery

Vedaly delivers hands-on analytical and technical work across bioinformatics, translational analytics, and AI/ML development. We integrate and analyze complex biological, clinical, and real-world data to generate insights you can trust — and build models that are interpretable, reproducible, and decision-ready. Whether augmenting your team or leading delivery, we focus on results that stand up to scientific and operational scrutiny.

news

01 November 2025

We are now Vedaly!

To reflect the expanded scope of our services and platform, OmicsChart is now called Vedaly.

Learn more

15 June 2024

OmicsChart on stage at WMF - We Make Future 2024 in Italy

OmicsChart CEO, Tanya Aneichyk, presented our cutting-edge omics data solution at the WMF - We Make Future 2024 conference in Italy.

Learn more

04 June 2024

OmicsChart joins Milner Therapeutics Institute network

OmicsChart joined the Affiliated Companies network at the Milner Therapeutics Institute, Cambridge University, UK.

Learn more